Associations of cardiometabolic index with diabetic statuses and insulin resistance: the mediating role of inflammation-related indicators
Open Access
- 8 October 2024
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-14
Abstract
This study aimed to analyze the associations of cardiometabolic index (CMI) with diabetic statuses and insulin resistance (IR) using data from the National Health and Nutrition Examination Survey (NHANES) and examined the potential mediating role of inflammation in these correlations. This study enrolled 9477 participants across four NHANES cycles from 2011 to 2018. The primary outcomes of the study included the risk of having prediabetes, diabetes and the level of the homeostasis model assessment of IR (HOMA-IR). Other outcomes including the levels of fasting blood glucose (FBG), hemoglobin A1c (HbA1c), oral glucose tolerance test (OGTT) results, fasting insulin, the risk of oral hypoglycemic medicine use, insulin use, and retinopathy were also collected and analyzed. Logistic regression model, subgroup analysis, restricted cubic spine (RCS), and Pearson correlation coefficients were conducted to assess the associations of CMI with diabetic statuses and IR. The mediating role of inflammation was evaluated to investigate the potential mechanism of the associations between CMI and diabetic statuses. Among included participants, the CMI levels in normal participants, prediabetes and diabetes in this study were 0.48, 0.73 and 1.07. After multivariable adjustment, CMI was positively associated with the risk of prediabetes (OR = 1.49, 95% CI = 1.24–1.79), diabetes (OR = 2.14, 95% CI = 1.82–2.50) and the level of HOMA-IR (β = 2.57, 95% CI = 2.14–3.01). Besides, an increased CMI was correlated with higher levels of FBG, HBA1c, OGTT results and fasting insulin as well as the greater risk of oral hypoglycemic medicine use and insulin use. The RCS showed an inverted L-shaped association of CMI with prediabetes and diabetes (P for non-linearity < 0.001). According to Pearson correlation coefficients, higher CMI was linked to higher rises in HOMA-IR (r = 0.224, P < 0.001). Inflammation-related indicators including leukocyte and neutrophil demonstrated significant mediating effects in the associations of CMI with prediabetes (15.5%, 9.8%), diabetes (5.1%, 6.0%) and HOMA-IR (3.3%, 2.6%). CMI was positively associated with the risk of worse diabetic statuses and higher level of IR while the associations may be partially mediated by inflammation-related indicators, suggesting that CMI could be a promising indicator for the prediction of severe diabetes and IR.Keywords
Funding Information
- National Natural Science Foundation of China (82170521)
- Shanghai Natural Science Foundation of China (21ZR1449500)
- Foundation of Shanghai Municipal Health Commission (202140263)
- Tibet Natural Science Foundation of China (XZ2022ZR-ZY27(Z))
- Foundation of Chongming (CKY2021-21)
- Clinical Research Plan of Shanghai Tenth People’s Hospital (YNCR2A001)
- Clinical Research Plan of SHDC (SHDC2020CR4065)
- Foundation of the Science and Technology Commission of Shanghai Municipality (20dz1207200)
This publication has 53 references indexed in Scilit:
- Cardiometabolic index is associated with urinary albumin excretion and renal function in aged person over 60: Data from NHANES 2011–2018International Journal of Cardiology, 2023
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Selective activation of PFKL suppresses the phagocytic oxidative burstCell, 2021
- Effect of anti-inflammatory therapy on major cardiovascular events in patients with diabetes: A meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Triglycerides and Residual Atherosclerotic RiskJACC, 2021
- Cardiometabolic index: a new tool for screening the metabolically obese normal weight phenotypeJournal of Endocrinological Investigation, 2020
- The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitusClinica Chimica Acta, 2015
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome XDiabetologia, 1997